Top Biotech Stock Gainers: GLYC, LRMR, MNMD
7:05 pm Thursday, May 13th, 2021
Here are the top biotech stock gainers on Thursday:
GlycoMimetics Inc (NASDAQ:GLYC) stock is trading higher by 12% at $2.52 on Thursday without any official news. Last week, the company said it as of March 31, 2021had cash and cash equivalents of $132.5 million as compared to $137.0 million as of December 31, 2020. The Company’s research and development expenses decreased to $11.2 million in the latest quarter as compared to $12.7 million for the same period in 2020.
Larimar Therapeutics Inc (NASDAQ:LRMR) soared over 12.50% to $11.66 on unusual volume. earlier this week, the company announced topline data from its Phase 1 multiple ascending dose (MAD) clinical trial (n=27) evaluating CTI-1601 as a treatment for FA. The stock has lost almost 55% from its 52-week high.
Mind Medicine (MindMed) Inc (NASDAQ: MNMD) stock is gaining momentum and soared 11.50% after the company it has appointed Peter Mack as the new Vice President of Pharmaceutical Development. As the company keeps working on a wide range of psychedelics-based medicines, Mack is going to lead the efforts related to product development for the entire portfolio.
